Sandbox:Polio prevention: Difference between revisions
Jump to navigation
Jump to search
Tarek Nafee (talk | contribs) No edit summary |
Tarek Nafee (talk | contribs) No edit summary |
||
Line 27: | Line 27: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center"| ✔ | | style="padding: 5px 5px; background: #F5F5F5;" align="center"| ✔ | ||
|- | |- | ||
| colspan="7" † <SMALL><SMALL>Countries at high risk for importation and subsequent spread</SMALL></SMALL><br> ‡ <SMALL><SMALL>Countries at high risk for importation and subsequent spread</SMALL></SMALL> | | colspan="7" | † <SMALL><SMALL>Countries at high risk for importation and subsequent spread</SMALL></SMALL><br> ‡ <SMALL><SMALL>Countries at high risk for importation and subsequent spread</SMALL></SMALL> | ||
|- | |- | ||
|} | |} |
Revision as of 16:13, 24 October 2016
Vaccine Type | Serotypes covered | Number of Doses | Vaccination Schedule in Endemic and High Risk Countries† | |||
---|---|---|---|---|---|---|
Birth | 6 weeks | 10 weeks | 14 weeks | |||
OPV | *Monovalent (Serotype 2) *Bivalent (Serotypes 1 & 3)‡ *Trivalent (Serotypes 1, 2, & 3) |
3 to 4 doses | ✔ | ✔ | ✔ | ✔ |
IPV | *Serotype 1 *Serotype 2 *Serotype 3 |
4 doses | ✔ | |||
† Countries at high risk for importation and subsequent spread ‡ Countries at high risk for importation and subsequent spread |